Louis Garguilo

ARTICLES BY LOUIS

  • Pharma’s Whole-Brained Sourcing Leaders
    Pharma’s Whole-Brained Sourcing Leaders

    Today in Pharma, procurement and sourcing leaders need to be whole-brained. Left-side and right-side skills and talents have become equally important in these outsourcing activities. Are we pointing to the two sides of human intellect as perfected in procurement? Well, yes, and here’s the explanation from Pharma’s sourcing leaders themselves.

  • Continuous Cruising The Pharma Highway
    Continuous Cruising The Pharma Highway

    Jim Bonner of Shire, Eric Jayjock of Patheon, and Doug Hausner, of  Rutgers University, all agree continuous manufacturing is the pharmaceutical industry’s future. They also agree on the map and vehicle to get us past some of the roadblocks to that destination.

  • Supply Chain Acronyms Lead Bristol-Myers Squibb
    Supply Chain Acronyms Lead Bristol-Myers Squibb

    Bristol-Myers Squibb focuses on reduction in total cost of ownership (TCO) while capturing value-based savings (VBS) in its supplier relationship management (SRM) strategy. A bit to unpack there. We get help from Keith Robinson, Associate Director at BMS, and an originator of the BMS Global Supplier Performance and Development Initiative.

  • Leadership From Retirement: Find “The Freedom To Operate”
    Leadership From Retirement: Find “The Freedom To Operate”

    This is not a piece on retirement. It is, though, borne of the potential for supreme satisfaction when that milestone is attained. The “post years” will have much to do with financial means, but that feeling of satisfaction will also result from your “freedom to operate” during your decades of employment, and how you put that freedom to use.  

  • Biologics Staying Home, CMOs Destination For Small Molecules
    Biologics Staying Home, CMOs Destination For Small Molecules

    Jim Miller, President, PharmSource Information Services, Inc., sounds as much like a travel agent as a pharma outsourcing prognosticator at his DCAT Week ’17 market overview on pharmaceutical contract development and manufacturing: Pharma’s billions for biologics are staying home; small molecules continue to hit the road.

  • Biotechs And Pharma Crystal Clear On Awards: CMOs Must Take All
    Biotechs And Pharma Crystal Clear On Awards: CMOs Must Take All

    Pharma and Bio in fact know exactly what they want from their contract development and manufacturing organizations: They want it all. In errant thought at the CMO Leadership Awards leads to the conclusion CMOs can’t be good at a few outsourcing services.

  • The Argument Against Outsourcing
    The Argument Against Outsourcing

    You never thought you’d see a headline like that in Outsourced Pharma.  But I’ve rarely heard so clearly articulated the need for a deep rationalization for outsourcing. So while this is unusual for us, the industry won’t continue its amazing progress unless clearly understanding the points against as well as our points in support.  

  • Is Your Outsourcing Reliable, Responsive, And Continuously Compliant?
    Is Your Outsourcing Reliable, Responsive, And Continuously Compliant?

    “What would happen if you lined up what I'm concerned about, with the concerns of the CMOs?” asks Bob Sheroff, Senior Vice President, Technical Operations at Agios. Well, we are about to do just that at Outsourced Pharma Boston, where Sheroff will discuss: reliability of supply, continuous compliance, and responsiveness.

  • Generation Z, High-Fructose Sugar … And The Pharmaceutical Industry
    Generation Z, High-Fructose Sugar … And The Pharmaceutical Industry

    Thank high-fructose sugar for pulling at least one of the brightest of a new generation into the study of chemistry, potentially the business of pharmaceuticals, and maybe even the field of outsourcing drug development and manufacturing.

  • End Of An Outsourcing Era: Quality And Procurement In Balance
    End Of An Outsourcing Era: Quality And Procurement In Balance

    For those in drug development and manufacturing outsourcing through the first decade and a half of this new century, it’s now safe to glance back … and finally put an end to an era focused on costs. A look back, and prognosis for what comes next, in an interview with William A. (Al) Kentrup, VP Global Quality Compliance and Systems, Takeda Pharmaceutical Company.

Louis Garguilo

Louis Garguilo



Louis Garguilo is chief editor and conference chair for Outsourced Pharma, and a contributing editor to Life Science Leader magazine. He studied public relations and journalism at Syracuse University (and holds a Master’s in English), and has 30+ years of international experience in business communications and development positions. Louis spent a decade at a global pharmaceutical contract research, development and manufacturing organization; served under the governor of New York in the state’s economic development agency, as liaison to the pharmaceutical/biotechnology industry; was chief strategic officer for an e-learning software company; and spent most of the ‘80s and ‘90s in Japan as an educator, author, and business communications consultant, including for the Osaka Medical Center for Cancer and Cardiovascular Diseases.